Skip to main content
Equibles

GSK · GSK plc · Financials

Track GSK — free

Use GSK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GSK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$47.03 -0.15 (-0.32%) At close · Oct 2
Rebalance outlook locked
Market Cap
$98.62B
Shares
2.00B
Volume · Oct 2 5.39M Avg daily vol (3M) 3.68M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
32.67B +4.1%
FY2025 Revenue FY2015–FY2025
Net Income
5.72B +122%
FY2025 Net Income FY2015–FY2025
Gross Margin
72.4% +1.2pp
FY2025 Gross Margin FY2015–FY2025
Operating Margin
24.28% +11.5pp
FY2025 Operating Margin FY2015–FY2025
Diluted EPS
1.39 +123.2%
FY2025 Diluted EPS FY2015–FY2025
Operating Cash Flow
7.74B +18.1%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
GBP 32.67B 31.38B 30.33B 29.32B 24.7B 24.35B 33.75B 30.82B 30.19B 27.89B 23.92B
GBP 9.02B 9.05B 8.57B 9.55B 8.16B 7.93B 11.86B 10.24B 10.34B 9.29B 8.85B
GBP 23.65B 22.33B 21.76B 19.77B 16.53B 16.43B 21.89B 20.58B 19.84B 18.6B 15.07B
GBP 7.53B 6.4B 6.22B 5.49B 5.02B 4.79B 4.57B 3.89B 4.48B 3.63B 3.56B
GBP 202M 198M 199M 192M 169M 176M 393M 389M 405M 395M 376M
GBP 2.31B 2.55B 2.29B 2.15B 2.12B 2.05B 2.33B 1.86B 1.92B 1.77B 1.63B
GBP 7.93B 4.02B 6.75B 6.43B 4.36B 5.98B 6.96B 5.48B 4.09B 2.6B 10.32B
GBP 701M 669M 792M 879M 769M 874M 912M 798M 734M 736M 757M
GBP 7.4B 3.48B 6.06B 5.63B 3.6B 5.17B 6.22B 4.8B 3.53B 1.94B 10.53B
GBP 1.11B 526M 756M 707M 83M 67M 953M 754M 1.36B 877M 2.15B
GBP 5.72B 2.58B 4.93B 14.96B 4.39B 5.75B 4.65B 3.62B 1.53B 912M 8.42B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: 1.38B in buybacks, 39.21B in dividends.

Debt Profile

Annual debt figures are established from annual reports and updated by subsequent interim reports and event disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1131399 CUSIP 37733W204 13F (30d) 32 filings 22 filers Visit website Investor relations